Historical salary details - Mr. Keith A. Katkin, Independent Director, Syndax Pharmaceuticals Inc
Mr. Keith A. Katkin is the Independent Director of Syndax Pharmaceuticals Inc. They also hold 1 other positions in and Emergent Biosolutions Inc.
Mr. Keith A. Katkin
Independent Director
-
Gross Remuneration
-
Current Company
Syndax Pharmaceuticals Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Syndax Pharmaceuticals Inc | Independent Director | - | - |
| 2024 | Emergent Biosolutions Inc | Independent Director | - | - |
| 2023 | Eledon Pharmaceuticals Inc | Chairman of the Board | 1.5 M | - |
| 2023 | Emergent Biosolutions Inc | - | 397.0 K | -11.0 % |
| 2023 | Syndax Pharmaceuticals Inc | Independent Director | - | - |
| 2022 | Emergent Biosolutions Inc | Independent Director | 446.3 K | - |
| 2022 | Syndax Pharmaceuticals Inc | Independent Director | 372.9 K | -15.7 % |
| 2022 | Rigel Pharmaceuticals | Independent Director | 27.7 K | -88.2 % |
| 2022 | Eledon Pharmaceuticals Inc | Chairman of the Board | - | - |
| 2022 | Rigel Pharmaceuticals | Independent Director | - | - |
| 2021 | Syndax Pharmaceuticals Inc | Independent Director | 442.2 K | 72.6 % |
| 2021 | Rigel Pharmaceuticals | Independent Director | 235.4 K | 74.8 % |
| 2021 | Eledon Pharmaceuticals Inc | Chairman of the Board | 175 K | -92.6 % |
| 2021 | Emergent Biosolutions Inc | Independent Director | - | - |
| 2020 | Eledon Pharmaceuticals Inc | Chairman of the Board | 2.4 M | 2658.7 % |
| 2020 | Syndax Pharmaceuticals Inc | Independent Director | 256.3 K | 15.8 % |
| 2020 | Rigel Pharmaceuticals | Independent Director | 134.7 K | -6.3 % |
| 2019 | Syndax Pharmaceuticals Inc | Independent Director | 221.2 K | - |
| 2019 | Rigel Pharmaceuticals | Independent Director | 143.8 K | -19.3 % |
| 2019 | Eledon Pharmaceuticals Inc | Chairman of the Board | 86.2 K | -19.4 % |
| 2018 | Rigel Pharmaceuticals | Independent Director | 178.2 K | 31.5 % |
| 2018 | Eledon Pharmaceuticals Inc | Chairman of the Board | 106.9 K | -42.0 % |
| 2018 | Syndax Pharmaceuticals Inc | Director | - | - |
| 2017 | Syndax Pharmaceuticals Inc | Director | 376.1 K | - |
| 2017 | Eledon Pharmaceuticals Inc | Chairman of the Board | 184.3 K | - |
| 2017 | Rigel Pharmaceuticals | Independent Director | 135.5 K | 9.1 % |
| 2017 | KalVista Pharmaceuticals Inc | - | 29.2 K | - |
| 2016 | Rigel Pharmaceuticals | Independent Director | 124.1 K | -57.5 % |
| 2016 | KalVista Pharmaceuticals Inc | Independent Director | - | - |
| 2016 | Syndax Pharmaceuticals Inc | Independent Director | - | - |
| 2016 | Eledon Pharmaceuticals Inc | Chairman of the Board | - | - |
| 2015 | Rigel Pharmaceuticals | Independent Director | 291.8 K | - |
| 2015 | KalVista Pharmaceuticals Inc | Independent Director | 147.4 K | -13.8 % |
| 2014 | KalVista Pharmaceuticals Inc | Independent Director | 170.9 K | - |